Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-047231)

Filing Details

Accession Number:: 0001209191-11-047231
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-09 13:22:18
Reporting Period:: 2011-08-08

Filing Date:: 2011-09-09
Accepted Time:: 2011-09-09 13:22:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1349077	Lisa Kelly	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139	Svp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-08	953	$18.93	37,661	No	4	M	Direct
Common Stock	Disposition	2011-09-08	953	$47.50	36,708	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2011-08-31	953	$0.00	953	$18.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,813	2008-05-15	2018-05-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,520	Indirect	401(k)

Footnotes

Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/07/2008, except that the first quarterly vesting occurred on May 15, 2008.